Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice

BACKGROUND: Convalescent plasma and fractionated immunoglobulins have been suggested as prophylactic or therapeutic interventions during an influenza pandemic. FINDINGS: Intravenous immunoglobulin (IVIG) preparations manufactured from human plasma collected before the 2009 H1N1 influenza pandemic, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohenadl, Christine, Wodal, Walter, Kerschbaum, Astrid, Fritz, Richard, Howard, M Keith, Farcet, Maria R, Portsmouth, Daniel, McVey, John K, Baker, Donald A, Ehrlich, Hartmut J, Barrett, P Noel, Kreil, Thomas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996311/
https://www.ncbi.nlm.nih.gov/pubmed/24739285
http://dx.doi.org/10.1186/1743-422X-11-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996311/
https://www.ncbi.nlm.nih.gov/pubmed/24739285
http://dx.doi.org/10.1186/1743-422X-11-70

Ejemplares similares